Amsterdam - Delayed Quote • EUR IMCD N.V. (IMCD.AS) Follow Compare 135.35 +1.15 +(0.86%) At close: January 14 at 5:35:14 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations IMCD to acquire the life science business of YCAM in South Korea and expand its footprint in the beauty and personal care markets IMCD to acquire the life science business of YCAM in South Korea From left to right: JaeJoong Kim, Sales Director of YCAM, Fenna van Zanten, Director M&A and member of IMCD Group Executive Committee, Munkyum Kim, CEO of YCAM, Dongjoon Lee, Managing Director of IMCD Korea, Peter Shin, Finance Director of IMCD Korea ROTTERDAM, The Netherlands (18 December 2024) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution and formulation partner of speciality chemicals and ingredients, has sign IMCD China strengthens its life science business with the acquisition of Daoqin Photo_IMCD China strengthens its lifescience business with the acquisition of Daoqin (Left) Nicky Huang, Managing Director of IMCD China and IMCD Sanrise(Right) Jack Ning, General Manager of Daoqin ROTTERDAM, The Netherlands (13 December 2024) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner and formulator of speciality chemicals and ingredients, today announces that IMCD has signed an agreement to acquire the business of the food and nutraceutical ingredient distributor: At €142, Is IMCD N.V. (AMS:IMCD) Worth Looking At Closely? IMCD N.V. ( AMS:IMCD ), is not the largest company out there, but it saw significant share price movement during recent... IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION.PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.ROTTERDAM, The Netherlands (13 IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION.PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. ROTTERDAM, The Netherlands (1 IMCD NV (IMCDY) Q3 2024 Earnings Call Highlights: Strong EBITA Growth Amid Market Volatility IMCD NV (IMCDY) reports robust EBITA growth and strategic acquisitions, while navigating market uncertainties and cash flow challenges. IMCD reports EBITA of EUR 403 million in the first nine months of 2024 Rotterdam, The Netherlands (8 November 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its first nine months 2024 results.HIGHLIGHTS• Gross profit increase of 6% to EUR 909 million (+8% on a constant currency basis)• Operating EBITA increase of 1% to EUR 403 million (+3% on a constant currency basis)• Free cash flow of EUR 299 million (first nine months of 2023: EUR 364 million)• Cash earnings Returns At IMCD (AMS:IMCD) Appear To Be Weighed Down There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to... IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America Photo_IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America Photographed, from left to right:•Roberto Blum, CEO Blumos Group •Myriam Araya, General Manager Solutec•Nicolas Kaufmann, Latin America President IMCD•Ofelia Carranza, General Manager Sonutra Blumos•Nicolas Kantorowicz, General Manager Blumos S.A ROTTERDAM, The Netherlands (17 October 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading distributor of speciality chemicals and ingredients, Those who invested in IMCD (AMS:IMCD) five years ago are up 130% The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if... Can IMCD N.V. (AMS:IMCD) Maintain Its Strong Returns? While some investors are already well versed in financial metrics (hat tip), this article is for those who would like... With 57% ownership, IMCD N.V. (AMS:IMCD) boasts of strong institutional backing Key Insights Given the large stake in the stock by institutions, IMCD's stock price might be vulnerable to their... IMCD successfully issues a EUR 500 million rated bond IMCD_logo Logo IMCD ROTTERDAM, The Netherlands (29 August 2024, 17:45 hrs CEST) – IMCD N.V. (“IMCD”) a leading distributor of speciality chemicals and food ingredients, today successfully issued a new EUR 500 million rated corporate bond loan with institutional investors. This new EUR 500 million rated senior unsecured bond loan matures on 30 April 2030 and has a fixed coupon of 3.625%. The bond will be traded on the EURO MTF market on the Luxembourg Stock Exchange and received a Baa3 rating by Estimating The Intrinsic Value Of IMCD N.V. (AMS:IMCD) Key Insights Using the 2 Stage Free Cash Flow to Equity, IMCD fair value estimate is €172 With €142 share price, IMCD... IMCD N.V. (AMS:IMCD) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year Investors in IMCD N.V. ( AMS:IMCD ) had a good week, as its shares rose 3.8% to close at €137 following the release of... IMCD First Half 2024 Earnings: EPS: €2.48 (vs €2.68 in 1H 2023) IMCD ( AMS:IMCD ) First Half 2024 Results Key Financial Results Revenue: €2.39b (up 4.2% from 1H 2023). Net income... This IMCD Insider Increased Their Holding By 658% Last Year Insiders were net buyers of IMCD N.V.'s ( AMS:IMCD ) stock during the past year. That is, insiders bought more stock... IMCD reports EBITA of EUR 270 million in the first half of 2024 IMCD_logo Logo IMCD Rotterdam, The Netherlands (2 August 2024) - IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its first half year 2024 results. HIGHLIGHTS • Gross profit increase of 4% to EUR 607 million (+5% on a constant currency basis)• Operating EBITA decline of 4% to EUR 270 million (-2% on a constant currency basis)• Free cash flow of EUR 221 million (first half of 2023: EUR 241 million)• Cas Is It Too Late To Consider Buying IMCD N.V. (AMS:IMCD)? IMCD N.V. ( AMS:IMCD ), might not be a large cap stock, but it received a lot of attention from a substantial price... IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica IMCD_logo Logo IMCD ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to acquire 100% of the shares in Selechimica S.R.L. (“Selechimica”), an Italian distributor in the pharmaceutical industry. Headquartered in Milan, Italy, Selechimica distributes an extensive portfolio of Active Pharmaceutical Ingredients (APIs). With 3 employees, Selechimica represe Performance Overview Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is AEX-Index Return IMCD.AS AEX-Index YTD -3.42% +1.51% 1-Year -9.04% +13.19% 3-Year -13.82% +11.83%